Effects of COVID-19 on the regulatory landscape

Key learnings for facilitating global collaboration

Over a year into the COVID-19 pandemic, cases and deaths in some areas of the world are on the decline, while other areas continue to grapple with increasing case numbers and challenges in vaccine distribution.

Regulatory and health agencies worldwide have responded as the situation unfolds, focusing not only on COVID-19-specific development, testing and treatment but also on minimizing the impact of the pandemic on ongoing and future clinical trials.

In this report, we review and summarize regulatory responses and how COVID-19 will affect regulatory operations in the longer term.

Download the report by filling in the form on the right